FIELD: medicine.
SUBSTANCE: method of morphometric prediction of the course of diffuse large B-cell lymphoma based on the index of the proportion of p16INK4A- and p14ARF-positive tumour cells in the lymph nodes, characterized by the following: after a biopsy of the lymph nodes, immunohistochemical staining is performed on histological preparations and the relative number of tumour cells expressing p16INK4A and p14ARF is calculated morphometrically, then the index of the proportion of p16INK4A- and p14ARF-positive tumour cells is determined. If index values are less than 36%, a favourable course of diffuse large B-cell lymphoma is predicted, and with at least 36% an unfavourable outcome of the disease is predicted.
EFFECT: provision of objective criteria for predicting diffuse large B-cell lymphoma.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MORPHOMETRIC PREDICTION OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BY THE CONTENT OF P14ARF-POSITIVE TUMOR CELLS IN THE LYMPH NODES | 2022 |
|
RU2785907C1 |
METHOD OF MORPHOMETRIC PREDICTION OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BASED ON THE CONTENT OF AIF-POSITIVE TUMOR CELLS IN THE LYMPH NODES | 2023 |
|
RU2798958C1 |
METHOD FOR MORPHOMETRIC ESTIMATION OF THE PROGNOSIS OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BY THE INDEX OF THE PROPORTION OF TUMOUR CELLS EXPRESSING PSTAT3 AND PAKT1 IN LYMPH NODES | 2021 |
|
RU2767693C1 |
METHOD FOR MORPHOMETRIC ASSESSMENT OF THE PREDICTION OF DIFFUSE B-LARGE-CELL LYMPHOMA BY CONTENT OF STAT3+ CELLS IN TUMOR TISSUE | 2019 |
|
RU2710591C1 |
METHOD FOR MORPHOMETRIC ASSESSMENT OF A DIFFUSE B-LARGE-CELL LYMPHOMA PREDICTION BY STAT3+ TUMOR CELL COUNT IN LYMPH NODES | 2018 |
|
RU2694838C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF DIFFUSE LARGE B-CELL LYMPHOMAS | 2020 |
|
RU2750103C1 |
METHOD FOR MORPHOMETRIC ESTIMATION OF PREDICTION OF CLINICAL COURSE OF NODULAR SCLEROSIS OF HODGKIN LYMPHOMA BY A PERCENTAGE SCORE CD163+ AND CD68+ MACROPHAGES IN LYMPH NODES | 2020 |
|
RU2738863C1 |
METHOD OF EARLY PREDICTION OF RENAL DYSFUNCTION DEVELOPMENT IN PATIENTS WITH DIFFUSED B-LARGE CELL LYMPHOMA AT THE STAGE OF INDUCTION IMMUNOPOLYCHEMOTHERAPY | 2022 |
|
RU2799126C1 |
PREDICTION METHOD FOR LYMPHOMA CLINICAL COURSE SEVERITY AND TREATMENT EFFICIENCY | 2007 |
|
RU2345367C1 |
METHOD OF DIFFERENTIATED TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOSARCOMAS OF LYMPHOID ORGANS IN ADULTS | 2009 |
|
RU2421217C2 |
Authors
Dates
2024-03-05—Published
2023-08-07—Filed